Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

452 public trials 124 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Recruiting

FT839 in Autoimmune Diseases

NCT07800871

Conditions
ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arthritis, +26 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Recruiting

Controlling Hyperactive Immunity With Long-lived Lymphocytes

NCT07473154

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +13 more
Locations
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
  • Guy's & St Thomas NHS Foundation Trust London, United Kingdom
  • Royal Free London NHS Foundation Trust London, United Kingdom
View Trial Details
Recruiting

Platform Clinical Study for Conquering Scleroderma

NCT06195072

Conditions
Connective Tissue Diseases, Interstitial Lung Disease Due to Systemic Disease, Lung Diseases, +7 more
Locations
  • University of Alabama - Division of Pulmonary and Critical Care Medicine Birmingham, Alabama, United States
  • Keck School of Medicine at USC Medical Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Los Angeles (UCLA) Ronald Reagan Medical Center Los Angeles, California, United States
View all 34 locations
View Trial Details
Recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

NCT06328777

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +10 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

NCT06733935

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +23 more
Locations
  • Nkarta Investigational Site Orange, California, United States
  • Nkarta Investigational Site Gainesville, Florida, United States
  • Nkarta Investigational Site Miami, Florida, United States
  • Nkarta Investigational Site Plantation, Florida, United States
View all 18 locations
View Trial Details

Related conditions